Biologically Active Small Molecules

An internal standard for the quantification of AEA by GC- or LC-MS.

An internal standard for the quantification of AEA by GC- or LC-MS.

An internal standard for the quantification of AEA by GC- or LC-MS.

Produced endogenously via oxidation of AEA, or by transacylation of arachidonoyl CoA has analgesic activities in whole animal experiments, yet is a very poor ligand for the CB1 receptor.

Produced endogenously via oxidation of AEA, or by transacylation of arachidonoyl CoA has analgesic activities in whole animal experiments, yet is a very poor ligand for the CB1 receptor.

Produced endogenously via oxidation of AEA, or by transacylation of arachidonoyl CoA has analgesic activities in whole animal experiments, yet is a very poor ligand for the CB1 receptor.

Produced endogenously via oxidation of AEA, or by transacylation of arachidonoyl CoA has analgesic activities in whole animal experiments, yet is a very poor ligand for the CB1 receptor.

An internal standard for the quantification of NAGly by GC- or LC-MS.

An internal standard for the quantification of NAGly by GC- or LC-MS.

An internal standard for the quantification of NAGly by GC- or LC-MS.

A nitroaniline fatty acid amide used to measure FAAH activity exposure to FAAH activity results in the release of the yellow colorimetric dye m-nitroaniline (&epsilon = 13,500 at 410 nm) allowing the fast and convenient measurement of FAAH

A nitroaniline fatty acid amide used to measure FAAH activity exposure to FAAH activity results in the release of the yellow colorimetric dye m-nitroaniline (&epsilon = 13,500 at 410 nm) allowing the fast and convenient measurement of FAAH